Immune pleiotropic effect of telmisartan in arterial hypertension

Arterial hypertension (AH) is among the life-threatening diseases and requires permanent antihypertensive therapy, including telmisartan. However, the effect of telmisartan upon systemic interleukin profile in elderly hypertensive patients requires further study, due to the limited data on previousl...

Full description

Bibliographic Details
Published in:	Медицинская иммунология
Main Authors:	N. M. Agarkov, K. F. Makkonen, A. A. Titov, D. N. Belchikova, L. V. Kolpina
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2022-07-01
Subjects:	blood interleukins telmisartan arterial hypertension
Online Access:	https://www.mimmun.ru/mimmun/article/view/2476

Similar Items

Sartans in the treatment of arterial hypertension: focus on telmisartan and azilsartan. A review
by: Vadim D. Zakiev, et al.
Published: (2023-11-01)

TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY
by: V. I. Podzolkov, et al.
Published: (2015-12-01)

Advantages of telmisartan pharmacotherapy in elderly patients with arterial hypertension and metabolic syndrome who have suffered an ischemic stroke
by: O. A. Osipova, et al.
Published: (2022-10-01)

The use of telmisartan in patients with refractory arterial hypertension and obesity
by: I. Е. Deneka, et al.
Published: (2019-03-01)

Treatment of hypertension in obese patients: focus on telmisartan
by: I. E. Deneka, et al.
Published: (2018-12-01)

A multicenter, open-label study of the efficacy and safety of telmisartan in mild to moderate hypertensive patients
by: Plavnik Frida Liane, et al.
Published: (2002-01-01)

A comparative study on the pleiotropic effects of Olmesartan and Telmisartan in hypertensive patients with type 2 diabetes mellitus: A randomized, prospective, open labelled, hospital based study
by: Vineela Karthik N, et al.
Published: (2023-07-01)

The Antihypertensive Efficacy of Chlorthalidone and Telmisartan in Indian Hypertensive Patients who were Uncontrolled with Hydrochlorothiazide and Telmisartan Combination-A Prospective and an Open Label Study
by: Suresh V Sagarad, et al.
Published: (2014-04-01)

Clinical Efficacy and Tolerability of Antihypertensive Therapy with Single Pill Combinations of Telmisartan in Patients with Arterial Hypertension in Clinical Practice According to the ON TIME Observational Study
by: F. T. Ageev, et al.
Published: (2023-01-01)

Features of change of intracardiac gemodynamics and functional state of myocardium under the impact of telmisartan in patients with hypertension
by: Koshlia V.I., et al.
Published: (2016-09-01)

Features of change of intracardiac gemodynamics and functional state of myocardium under the impact of telmisartan in patients with hypertension.
by: V. I. Koshlia, et al.
Published: (2015-09-01)

The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA
by: O. D. Ostroumova, et al.
Published: (2020-05-01)

Clinical use of a fixed-dose combination of telmisartan and indapamide in hypertension. Expert Council resolution
by: A. O. Konradi, et al.
Published: (2025-02-01)

Cardiometabolic properties of telmisartan: new perspectives for use
by: O. M. Drapkina, et al.
Published: (2015-12-01)

CLINICAL ADVANTAGES OF TELMISARTAN: FEATURES OF PHARMACOKINETICS, PHARMACODYNAMICS AND EFFECTS ON THE DAILY BLOOD PRESSURE PROFILE
by: O. D. Ostroumova, et al.
Published: (2017-09-01)

Comparative evaluation of serum apelin, visfatin, and lipid levels in overweight hypertensive patients on enalapril versus telmisartan therapy
by: Mina Khalid MOHAMMED, et al.
Published: (2024-09-01)

A Meta-analysis of antihypertensive effect of telmisartan versus candesartan in patients with essential hypertension
by: Di Zhao, et al.
Published: (2019-01-01)

Effect of telmisartan on blood pressure in patients of type 2 diabetes with or without complications
by: Pradeep Gadge, et al.
Published: (2018-01-01)

TELMISARTAN IN CARDIOVASCULAR RISK REDUCTION
by: О. D. Ostroumova, et al.
Published: (2018-02-01)

How to Choose the Optimal Single-Pill Combination of the First-Line Antihypertensive Drugs? The Benefits of Amlodipine and Telmisartan Combination
by: O. D. Ostroumova, et al.
Published: (2020-09-01)

Current Trends in the Treatment of Hypertension: Focus on Improving Prognosis. The Capabilities of an Amlodipine/Telmisartan Single-Pill Combination
by: O. D. Ostroumova, et al.
Published: (2020-01-01)

Influence of additional risk factors on the antihypertensive efficacy of eprosartan and telmisartan in patients with essential hypertension
by: V. V. Syvolap, et al.
Published: (2017-12-01)

Telmisartan and cardioprotection
by: McFarlane S
Published: (2011-11-01)

Comparison of the efficacy, safety, and tolerability of the FDC of telmisartan + bisoprolol with telmisartan + metoprolol succinate ER combination therapy for stage 1 and stage 2 hypertension: A double-blind, multicentric, phase-III clinical study
by: Gurpreet S Wander, et al.
Published: (2024-05-01)

Effectiveness and tolerability of fixed-dose combinations of telmisartan in patients with hypertension with metabolic syndrome and without metabolic changes
by: Dmitry A. Napalkov
Published: (2023-10-01)

Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients with Dyslipidemia and Hypertension: A Multicenter Randomized Clinical Trial
by: Sungjoon Park, MD, et al.
Published: (2024-01-01)

Effect of a fixed-dose combination of Telmisartan/S-amlodipine on circadian blood pressure compared with Telmisartan monotherapy: TENUVA-BP study
by: Bong-Joon Kim, et al.
Published: (2022-03-01)

Efficacy and safety of telmisartan monotherapy in the black hypertensive patient at a tertiary centre in Eastern Nigeria
by: C K Ijoma, et al.
Published: (2011-01-01)

Effects of telmisartan vs olmesartan on metabolic parameters, insulin resistance and adipocytokines in hypertensive obese patients Efectos de telmisartan vs olmesartan sobre parámetros antropométricos, resistencia a la insulina y adipocitoquinas en pacientes hipertensos obesos
by: D. A. de Luis, et al.
Published: (2010-04-01)

Association of the protective effect of telmisartan on hearing loss among patients with hypertension
by: Jung-Joon Cha, et al.
Published: (2024-08-01)

Changes in heart rate variability in patients with hypertension under outpatient stage treatment
by: V. I. Koshlia, et al.
Published: (2015-12-01)

Central blood pressure lowering effect of telmisartan‐rosuvastatin single‐pill combination in hypertensive patients combined with dyslipidemia: A pilot study
by: JungMin Choi, et al.
Published: (2021-09-01)

Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double‐blind, multicenter, therapeutic confirmatory, phase III clinical trial
by: Chan Joo Lee, et al.
Published: (2024-03-01)

Decoding Drug Interactions: Character and Degree of Pharmacokinetic Interactions Between Telmisartan and Sorafenib or Donafenib in Rats
by: Li Y, et al.
Published: (2025-07-01)

FIXED COMBINATIONS IN ARTERIAL HYPERTENSION TREATMENT: NOVEL OPPORTUNITIES
by: V. I. Podzolkov, et al.
Published: (2018-06-01)

Pharmacokinetic and Bioequivalence Study of Telzap AM<sup>®</sup> (Telmisartan/amlodipine Fixed-dose Combination) and Coadministered Mikardis<sup>®</sup> (Telmisartan) and Norvask<sup>®</sup> (Amlodipine) in Healthy Subjects
by: V. Kubesh, et al.
Published: (2020-11-01)

The potential anticancer activities of telmisartan – a literature review
by: Andriana Hadjiyianni, et al.
Published: (2023-09-01)

Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity
by: Ayza MA, et al.
Published: (2020-10-01)

ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2017-07-01)

Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease
by: Victor Gustavo Balera Brito, et al.
Published: (2020-11-01)